Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04146909 · ClinicalTrials.gov registry record · NA
The Effect of Lactation on Insulin Sensitivity and Lipolysis in Women
A NA study, sponsored by Yale University.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT04146909: Clinical Trial NA study, sponsored by Yale University.
NCT04146909 is a NA study that was terminated before completion, run by Yale University. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04146909, a NA study, was terminated before completion, sponsored by Yale University.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
This purpose of this study is to investigate whether lactation improves insulin sensitivity and increases lipolysis in women.
Primary Outcome
The glucose infusion rate is determined by the amount of 20% dextrose given during the hyperinsulinemic-euglycemic clamp study, necessary to keep blood glucose levels at the target range (90-100 mg/dL). Higher rates of infused dextrose indicates greater sensitivity to infused insulin during the hyperinsulinemic-euglycemic clamp. Women with gestational diabetes are expected to be insulin resistant.
Interventions
- DIAGNOSTIC_TEST Hyperinsulinemic-euglycemic clamp
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2020-11-17 |
| Est. Completion | 2022-11-28 |
| Phase | NA |
Why NCT04146909 stopped before completion
NCT04146909 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Hyperinsulinemic-euglycemic clamp is the first listed.
NCT04146909 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04146909 about?
NCT04146909 is a clinical study titled "The Effect of Lactation on Insulin Sensitivity and Lipolysis in Women". This purpose of this study is to investigate whether lactation improves insulin sensitivity and increases lipolysis in women.
What is the current status of trial NCT04146909?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2020-11-17. Estimated completion is 2022-11-28.
What interventions are being tested in trial NCT04146909?
The interventions under investigation include: Hyperinsulinemic-euglycemic clamp (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04146909?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04146909's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI